Hong Kong stock market anomaly | Sanliv Pharma (01530.HK) surges more than 4% to hit new high as Pfizer authorization agreement officially takes effect, with $150 million reselling of 707 Mainland Chinese rights.

According to the Intelligent Wealth APP, Sansei Pharmaceuticals (01530.HK) rose over 4% to a new high, as of the time of writing, it rose by 3.45% to 33 Hong Kong dollars with a trading volume of 895 million Hong Kong dollars.